Based on the current findings, it will be worthwhile to determine whether reducing weight will be associated with changes in blood biomarkers both because of their link to the pathogenesis of breast cancer and because they correlate with levels of intra-breast aromatase. This evidence concerns the gene CYP19A1 and breast cancer.